All In MedTech

Device Trial Radar · NCT04031040

A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults

A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults.

Last checked: Nov 20, 2026Latest source record: Mar 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Sep 1, 2019

Primary completion

Oct 30, 2026

Study completion Oct 2030

Sponsor

Lead sponsor
Nyxoah S.A.Not on our public-company list
Sponsor type
Industry
First posted
Jul 24, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to confirm the safety and clinical effectiveness of the Genio® system in moderate to severe Obstructive Sleep Apnea (OSA) adult patients over a period of 5 years post-surgery.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • Genio® system therapyDevice

    Hypoglossal nerve stimulation system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of device-related Serious Adverse Events (SADEs)Time frame: 12 months post-surgery
  2. Change in Apnea-Hypopnea Index from baselineTime frame: 12 months post-surgery
  3. Change in the quality of life measured by the Functional Outcomes of Sleep QuestionnaireTime frame: 12 months post-surgery

Locations

19 sites in 5 countries. Site status is shown where the registry gives one.

  • Ziekenhuis Netwerk Antwerpen - ZNA Jan Palfijn

    Antwerp, Belgium

  • Universitair Ziekenhuis Antwerpen

    Antwerp, Belgium

  • CHU - Angers

    Angers, France

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.